Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.
Saved in:
| Title: | Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease. |
|---|---|
| Authors: | Virachit S; Neuroscience Research Australia, Randwick, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia., Mathews KJ; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia., Cottam V; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia., Werry E; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Galli E; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Rappou E; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Lindholm P; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Saarma M; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Halliday GM; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Central Clinical School, University of Sydney, Sydney, Australia., Shannon Weickert C; Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, Australia.; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY., Double KL; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia. |
| Source: | Brain pathology (Zurich, Switzerland) [Brain Pathol] 2019 Nov; Vol. 29 (6), pp. 813-825. Date of Electronic Publication: 2019 Jun 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-3639 (Electronic) Linking ISSN: 10156305 NLM ISO Abbreviation: Brain Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31033033 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Virachit+S%22">Virachit S</searchLink>; Neuroscience Research Australia, Randwick, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Mathews+KJ%22">Mathews KJ</searchLink>; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Cottam+V%22">Cottam V</searchLink>; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Werry+E%22">Werry E</searchLink>; Faculty of Medicine and Health, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Galli+E%22">Galli E</searchLink>; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Rappou+E%22">Rappou E</searchLink>; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Lindholm+P%22">Lindholm P</searchLink>; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Saarma+M%22">Saarma M</searchLink>; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Halliday+GM%22">Halliday GM</searchLink>; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Central Clinical School, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Shannon+Weickert+C%22">Shannon Weickert C</searchLink>; Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, Australia.; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY.<br /><searchLink fieldCode="AU" term="%22Double+KL%22">Double KL</searchLink>; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216781%22">Brain pathology (Zurich, Switzerland)</searchLink> [Brain Pathol] 2019 Nov; Vol. 29 (6), pp. 813-825. <i>Date of Electronic Publication: </i>2019 Jun 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Society+of+Neuropathology%22">International Society of Neuropathology </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9216781 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-3639 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210156305%22">10156305 </searchLink><i>NLM ISO Abbreviation: </i>Brain Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31033033 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bpa.12730 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 813 Titles: – TitleFull: Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Virachit S – PersonEntity: Name: NameFull: Mathews KJ – PersonEntity: Name: NameFull: Cottam V – PersonEntity: Name: NameFull: Werry E – PersonEntity: Name: NameFull: Galli E – PersonEntity: Name: NameFull: Rappou E – PersonEntity: Name: NameFull: Lindholm P – PersonEntity: Name: NameFull: Saarma M – PersonEntity: Name: NameFull: Halliday GM – PersonEntity: Name: NameFull: Shannon Weickert C – PersonEntity: Name: NameFull: Double KL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2019 Nov Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1750-3639 Numbering: – Type: volume Value: 29 – Type: issue Value: 6 Titles: – TitleFull: Brain pathology (Zurich, Switzerland) Type: main |
| ResultId | 1 |